Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes. 

Though it is not yet clear why some COVID patients develop thyroiditis and some do not, researchers maintain that their findings “support the hypothesis of a direct thyroid gland involvement in SARS‐CoV‐2 infection.” 

The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas. 

Experts involved in the new research suggested that their findings are in line with that of conventional palliative radiotherapy

At the annual ASTRO meeting, experts shared that not only did the shortened protocol shave weeks off of the scheduled treatment plan, it also did not come at the expense of increased toxicity. 

As chemotherapy treatments improve, patients who respond well may be able to skip surgery with a low chance of recurrence.

When referring physicians agree with radiologists’ recommendations on the clinical necessity of follow-up imaging, three-quarters of patients go on to complete the additional exam.

Compared to a group of patients who had not been previously diagnosed with Lyme disease, those who had been infected displayed unusual activity in the frontal lobe of the brain on functional MRI scans.